Corbus Pharmaceuticals Holdings (CRBP) Change in Cash (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Change in Cash of $6.9 million in Q3 2025, up 506.56% quarter-over-quarter from $1.1 million in Q2 2025, and up 262.77% on a YoY basis from $1.9 million in Q3 2024.
Corbus Pharmaceuticals Holdings (CRBP) Change in Cash (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Change in Cash history runs 13 years deep, the most recent figure standing at $6.9 million for Q3 2025.
- In Q3 2025, Change in Cash rose 262.77% year-over-year to $6.9 million; the TTM figure through Sep 2025 stood at $7.6 million (down 7.51% YoY), while the FY2024 annual figure was $3.5 million, up 205.95% from the prior year.
- Change in Cash was $6.9 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $1.1 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $32.0 million in Q1 2022 to a low of -$31.3 million in Q2 2022.
- Historically, Change in Cash has averaged -$3.1 million across 5 years, with a median of $1.0 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Change in Cash slumped 1383.47% in 2022, then jumped 835.59% in 2024.
- A 5-year view of Change in Cash shows it stood at -$12.1 million in 2021, then surged by 137.64% to $4.6 million in 2022, then sank by 45.71% to $2.5 million in 2023, then sank by 189.9% to -$2.2 million in 2024, then soared by 411.87% to $6.9 million in 2025.
- The last three Change in Cash figures came in at $6.9 million (Q3 2025), $1.1 million (Q2 2025), and $1.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -45.97 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 143.80 Mn | 115.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.94 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | -2.23 Mn |
| Sep 30, 2024 | -4.26 Mn |
| Jun 30, 2024 | 9.58 Mn |
| Mar 31, 2024 | 379,000.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | -9.68 Mn |
| Dec 31, 2022 | 4.56 Mn |
| Sep 30, 2022 | -13.33 Mn |
| Jun 30, 2022 | -31.26 Mn |
| Mar 31, 2022 | 32.02 Mn |
| Dec 31, 2021 | -12.11 Mn |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | -30.88 Mn |
| Mar 31, 2021 | -18.82 Mn |
| Dec 31, 2020 | 3.56 Mn |